4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001193125-26-037697
President, CEO and CFO bought 125 shares at $4.61 ($576)
From the SEC's structured data for this filing
Trades in this filing
Quinn William P. · President, CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-05 | Purchase : show line 1 in the form | +125 | $4.61 | $576 | 2,313 | D |
| Open-market purchases · 125 sh · avg $4.61 · $576 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-28 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +20,000 | 20,000 | D |
Loading xslF345X05/ownership.xml…